Jazz pharmaceuticals plc (JAZZ)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Royalties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Contract revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Total revenues

2,188,301

2,161,761

2,056,478

1,988,149

1,954,495

1,890,922

1,850,864

1,793,346

1,687,253

1,618,693

1,578,915

1,541,241

1,528,016

1,487,973

1,432,233

1,398,924

1,351,510

1,324,803

1,312,064

1,277,776

1,235,259

1,172,875

1,080,507

1,006,083

923,105

872,423

820,352

763,707

679,686

585,979

485,812

383,590

323,926

272,277

233,494

200,687

0

0

0

Operating expenses:
Cost of product sales (excluding amortization of acquired developed technologies)

123,081

127,930

118,919

114,093

121,131

121,544

120,455

125,084

119,042

110,188

118,596

111,704

107,012

105,386

95,760

99,834

97,667

102,526

107,304

105,913

114,792

117,418

114,253

111,511

105,850

102,146

102,266

110,643

97,901

78,425

56,524

27,796

18,877

13,942

13,171

12,072

0

0

0

Selling, general and administrative

777,395

736,942

684,532

661,699

644,264

683,530

664,715

633,365

607,114

544,156

528,247

528,092

518,382

502,892

501,306

480,982

465,496

449,119

429,258

418,715

412,139

406,114

381,719

363,188

340,138

304,303

284,382

270,336

250,054

223,882

198,888

168,511

133,381

108,936

90,592

77,141

0

0

0

Research and development

325,728

299,726

259,001

230,306

224,054

226,616

235,954

232,156

216,181

198,442

176,605

177,039

175,973

162,297

147,594

150,582

139,324

135,253

130,357

101,996

94,253

85,181

74,431

63,834

52,994

41,632

35,100

30,194

23,265

20,477

16,964

13,323

14,384

14,120

17,673

22,356

0

0

0

Intangible asset amortization

360,776

354,814

227,867

211,993

205,376

201,498

207,856

208,180

179,407

152,065

125,326

104,466

105,017

101,994

99,522

99,196

96,127

98,162

106,449

110,952

120,079

126,584

115,131

104,065

90,669

79,042

80,425

80,603

74,174

65,351

45,306

27,426

16,318

7,448

7,448

7,630

0

0

0

Acquired in-process research and development

256,225

109,975

109,975

58,200

56,000

0

75,000

77,000

0

-

0

0

-

23,750

23,750

8,750

8,750

0

626

75,626

75,626

202,626

202,000

127,988

127,988

4,988

0

0

0

-

-

-

-

-

-

-

-

-

-

Impairment charge

136,139

0

0

42,896

0

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

1,979,344

1,629,387

1,400,294

1,276,291

1,293,721

1,276,084

1,279,876

1,324,681

1,206,744

1,089,851

1,025,774

938,301

921,384

896,319

899,455

870,867

838,887

816,583

780,553

819,761

856,254

977,288

920,340

803,392

717,639

532,111

507,161

495,776

449,394

388,135

317,682

237,056

182,960

144,446

128,884

119,199

0

0

0

Income (loss) from operations

208,957

532,374

656,184

711,858

660,774

614,838

570,988

468,665

480,509

528,842

553,141

602,940

606,632

591,654

532,778

528,057

512,623

508,220

531,511

458,015

379,005

195,587

160,167

202,691

205,466

340,312

313,191

267,931

230,292

197,844

168,130

146,534

140,966

127,831

104,610

81,488

0

0

0

Interest expense, net

-72,835

-72,261

-71,921

-72,980

-74,392

-77,075

-80,597

-80,869

-79,517

-77,756

-75,461

-74,767

-68,594

-61,942

-55,021

-49,173

-52,864

-56,917

-61,385

-63,265

-58,882

-52,713

-42,208

-33,880

-29,593

-26,916

-28,394

-29,942

-24,281

-16,869

-10,813

-3,188

-2,364

-1,600

1,192

6,004

0

0

0

Foreign exchange loss

-6,332

-5,811

-5,271

-4,994

-5,758

-6,875

-6,035

-7,503

-10,233

-9,969

-4,175

-2,700

2,727

3,372

523

295

-1,619

1,445

1,357

8,817

10,805

8,683

5,711

-1,386

-1,845

-1,697

-5,687

-3,974

-3,349

-3,620

1,339

0

0

-

0

-

-

-

-

Gain (Loss) on Extinguishment and Modification of Debt

-

-

0

0

-

-

0

0

-

-

0

0

-

-

0

-

-

-

0

0

-

-

0

0

-

-

0

0

-

-

0

0

-

-

0

-

-

-

0

Income (loss) before income tax provision (benefit) and equity in loss (gain) of investees

129,790

454,302

578,992

633,884

579,199

529,463

482,931

378,868

390,759

441,117

473,505

524,835

540,127

532,446

477,642

479,179

441,325

435,933

454,668

386,752

330,928

151,557

123,670

167,425

170,279

307,950

278,039

230,746

202,662

177,355

157,382

143,413

138,909

124,984

0

0

0

-

-

Interest income and other, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Income tax provision (benefit)

-153,600

-73,200

-33,446

-25,046

90,154

80,200

-38,668

-56,729

-57,714

-47,700

100,262

125,460

132,057

135,236

114,636

118,144

106,679

106,399

126,284

120,560

109,263

94,231

92,662

86,776

91,031

91,638

-49,186

-54,665

-71,677

-83,794

24,966

12,110

0

-

0

0

-

-

-

Equity in loss (gain) of investees

-3,014

-4,089

-3,634

-3,041

-2,759

-2,203

-1,732

-1,568

-1,185

-1,009

-913

-743

-540

-379

-103

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

261,149

127,425

0

0

-

0

-

-

-

-

Income from discontinued operations, net of taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27,437

-6,908

0

0

-

0

-

-

-

-

Net income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

329,534

328,384

266,192

221,665

57,326

31,008

80,649

79,248

216,312

0

0

0

-

-

-

-

-

-

-

-

-

-

Net loss attributable to noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-1,061

-1,060

-1,062

-989

0

0

0

0

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

280,333

523,367

608,845

655,885

486,308

447,098

519,835

434,045

447,328

487,848

372,330

398,632

407,530

396,831

368,102

366,388

0

-

0

0

-

58,387

32,068

81,711

80,237

216,312

361,570

319,370

304,330

288,586

125,508

124,781

130,838

124,984

100,754

61,884

0

0

0

Net income (loss) per ordinary share:
Basic:
Income from continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2.91

0.59

0.55

0.56

-

0.77

-

-

-

-

Income from discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.61

-0.01

-0.07

-0.05

-

0.00

-

-

-

-

Basic (in dollars per share)

-2.82

1.31

1.80

4.62

1.49

2.68

2.47

1.53

0.77

3.87

1.06

1.76

1.44

1.94

1.49

1.89

1.24

1.35

1.43

1.44

1.16

1.40

0.43

0.73

-1.58

0.95

1.30

0.72

0.74

3.52

0.58

0.48

0.51

0.89

0.77

0.81

0.54

0.34

-0.18

Diluted:
Income from continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2.75

0.56

0.51

0.52

-

0.69

-

-

-

-

Income from discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.56

-0.01

-0.06

-0.04

-

0.00

-

-

-

-

Diluted (in dollars per share)

-2.82

1.28

1.78

4.56

1.47

2.64

2.41

1.50

0.75

3.80

1.03

1.72

1.41

1.90

1.45

1.85

1.21

1.32

1.39

1.40

1.12

1.40

0.41

0.70

-1.58

0.88

1.23

0.69

0.71

3.31

0.55

0.45

0.48

0.79

0.69

0.71

0.48

0.32

-0.18

Weighted-average ordinary shares used in per share calculations - basic (in shares)

55,956

56,409

56,674

56,707

57,206

59,323

60,476

60,177

59,928

59,984

60,108

60,100

59,880

59,922

60,437

60,499

61,142

61,500

61,435

61,190

60,803

60,634

60,305

59,519

58,526

57,880

58,217

58,737

58,358

57,994

57,703

56,952

53,923

42,397

42,028

41,209

40,362

38,965

35,423

Weighted-average ordinary shares used in per share calculations - diluted (in shares)

55,956

57,254

57,438

57,427

58,081

60,411

61,857

61,438

61,178

61,191

61,436

61,463

61,178

61,026

61,795

62,043

62,616

62,936

63,154

63,090

62,964

66,872

62,680

62,378

58,526

61,678

61,519

61,568

61,511

61,259

60,883

60,554

58,084

47,653

47,241

46,601

45,697

41,737

35,423

Product sales, net
Total revenues

2,162,475

2,135,601

2,026,409

1,959,285

1,931,957

1,869,473

1,832,234

1,775,008

1,668,568

1,601,399

1,563,918

1,527,568

1,517,023

1,477,261

1,423,571

1,390,704

1,343,700

1,316,819

1,302,118

1,267,771

1,224,765

1,162,716

1,072,289

998,268

915,732

865,398

813,545

757,289

673,727

580,527

479,519

377,605

318,067

266,518

229,421

196,733

0

0

0

Royalties and contract revenues
Total revenues

25,826

26,160

30,069

28,864

22,538

21,449

18,630

18,338

18,685

17,294

14,997

13,673

10,993

10,712

8,662

8,220

7,810

7,984

9,946

10,005

10,494

10,159

8,218

7,815

7,373

7,025

6,807

6,418

5,959

5,452

6,293

5,985

5,859

5,759

0

0

0

-

-